Design and Baseline Characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)
Diabetes and Vascular Disease Research - United Kingdom
doi 10.1177/1479164115570301
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2015
Authors
Publisher
SAGE Publications